Drugs / BMS 587101
last change Jun 2006 re-read 3 minutes ago

BMS 587101

Developed for
psoriasis
Investigated by
Bristol-Myers Squibb

Trials 1

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00162253 Apr 2005 → Jun 2006 psoriasis Bristol-Myers Squibb Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BMS 587101 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00162253 ↗